Tandem Diabetes Care, Inc. (TNDM) Earnings History
Annual and quarterly earnings data from 2011 to 2025
Loading earnings history...
TNDM EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
TNDM Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 52.3% | -7.7% | -20.2% |
| 2024 | 52.1% | -10.5% | -10.2% |
| 2023 | 49.2% | -31.2% | -29.8% |
| 2022 | 51.5% | -11.6% | -11.8% |
| 2021 | 53.5% | 3.2% | 2.2% |
Download Data
Export TNDM earnings history in CSV or JSON format
Free sign-in required to download data
Tandem Diabetes Care, Inc. (TNDM) Earnings Overview
As of May 8, 2026, Tandem Diabetes Care, Inc. (TNDM) reported trailing twelve-month net income of -$95M, reflecting -106.8% year-over-year growth. The company earned $-1.38 per diluted share over the past four quarters, with a net profit margin of -20.2%.
Looking at the long-term picture, TNDM's historical earnings data spans multiple years. The company achieved its highest annual net income of $16M in fiscal 2021.
Tandem Diabetes Care, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PODD ($303M net income, 9.1% margin), DXCM ($930M net income, 17.9% margin), ABBV ($4.23B net income, 6.9% margin), TNDM has room to improve margins relative to the peer group. Compare TNDM vs PODD →
TNDM Earnings vs Peers
Earnings metrics vs comparable public companies
TNDM Historical Earnings Data (2011–2025)
15 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$205M | -113.2% | -$78M | $-3.04 | -20.2% | -7.7% |
| 2024 | -$96M | +56.9% | -$99M | $-1.47 | -10.2% | -10.5% |
| 2023 | -$223M | -135.3% | -$233M | $-3.43 | -29.8% | -31.2% |
| 2022 | -$95M | -707.7% | -$93M | $-1.47 | -11.8% | -11.6% |
| 2021 | $16M | +145.3% | $23M | $0.24 | 2.2% | 3.2% |
| 2020 | -$34M | -38.9% | -$8M | $-0.56 | -6.9% | -1.6% |
| 2019 | -$25M | +79.8% | -$17M | $-0.42 | -6.8% | -4.6% |
| 2018 | -$123M | -67.9% | -$45M | $-2.55 | -66.7% | -24.3% |
| 2017 | -$73M | +12.5% | -$63M | $-12.86 | -67.9% | -58.5% |
| 2016 | -$83M | -15.2% | -$78M | $-27.30 | -99.0% | -92.6% |
See TNDM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TNDM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TNDM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTNDM — Frequently Asked Questions
Quick answers to the most common questions about buying TNDM stock.
Is TNDM growing earnings?
TNDM EPS fell to $-1.38, with earnings declining -106.8%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-95M.
What are TNDM's profit margins?
Tandem Diabetes Care, Inc. net margin is -20.2%, with operating margin at -7.7%. Below-average margins reflect competitive or cost pressures.
How consistent are TNDM's earnings?
TNDM earnings data spans 2011-2025. The declining earnings trend is -106.8% YoY. Historical data enables comparison across business cycles.